Title: The Newly Proposed Plasma-Glycosylated Hemoglobin A1c/High-Density Lipoprotein
Cholesterol Ratio Serves as A Simple and Practical Indicator for Screening Metabolic
Associated Fatty Liver Disease: An Observational Study Based on A Physical Examination
Population
Version: 3 Date: 06 Aug 2024
Reviewer:  Mustafa Cesur
Reviewer's report:
The authors made the suggested corrections succesfully. I want to point only one thing. In line
50 the first paragraph of the manuscript starts with MAFLD. It should be like that; Metabolic
associated fatty liver disease (MAFLD).
Title: The Newly Proposed Plasma-Glycosylated Hemoglobin A1c/High-Density Lipoprotein
Cholesterol Ratio Serves as A Simple and Practical Indicator for Screening Metabolic
Associated Fatty Liver Disease: An Observational Study Based on A Physical Examination
Population
Version: 3 Date: 06 Aug 2024
Reviewer:  Mustafa Cesur
Reviewer's report:
The authors made the suggested corrections succesfully. I want to point only one thing. In line
50 the first paragraph of the manuscript starts with MAFLD. It should be like that; Metabolic
associated fatty liver disease (MAFLD).
Please review this paper.
user
Title: The Newly Proposed Plasma-Glycosylated Hemoglobin A1c/High-Density Lipoprotein
Cholesterol Ratio Serves as A Simple and Practical Indicator for Screening Metabolic
Associated Fatty Liver Disease: An Observational Study Based on A Physical Examination
Population
Version: 3 Date: 06 Aug 2024
Reviewer:  Mustafa Cesur
Reviewer's report:
The authors made the suggested corrections succesfully. I want to point only one thing. In line
50 the first paragraph of the manuscript starts with MAFLD. It should be like that; Metabolic
associated fatty liver disease (MAFLD).
assistant